Milk thistle capsules


Supports liver function and metabolism. Milk thistle constituents have a prophylactic and protective effect on the liver. Silymarin is an anti-oxidant that reduces hepato-cellular necrosis and fatty deposits in the liver. It’s regenerative action regenerates injured liver cells, reducing circulatory changes in the hepatic portal system. The anti-inflammatory action decreases SGOT (Serum glutamic oxaloacetic transaminase, a liver enzyme) in patients with chronic liver disease. Lessens risk of gallstone formation. Reduces the impact of environmental toxins and heavy metals. Used for cholelithiasis, liver cirrhosis, inflammatory conditions such as chronic hepatitis and fatty liver, varicosities and haemorrhoids.

400mg, 60 capsules.

Buy from Faithful To Nature


Flora Force Milk Thistle Capsules Package Insert

Scheduling status: C0

Proprietary name (and dosage form): Flora Force Milk Thistle Capsules 400mg.

Composition: Each capsule contains Silybum marianum powder 400mg.

Pharmacological classification: Category D Western Herbal Medicine

Pharmacological action: 11 Medicines acting on gastro-intestinal tract. 11.10 Others.

Indications: Herbal medicine for supporting of the liver function, assisting the kidney function, adrenal system, immune system and assists in the treatment of inflammatory bowel disease and psoriasis.

Contra-indications: For persons with an allergy to plants in the Compositae family.

Not to be taken during pregnancy or lactation.

In persons with hormone related conditions.

Milk Thistle is contra-indicated in hormone related cancers: breast, uterine, prostate,

Warnings: See contra-indications and Interactions.

Drug interaction: Possible interactions may occur, discuss with a practitioner before taking Milk Thistle

Diabetic drugs: Milk Thistle may lower blood sugar in persons with diabetes. A dose adjustment might be required.

Glipizide (Glucotrol), Tolbutamide (Tolinase),

Cardiac: Digoxin

Anti-hypertensive drugs: Irbesartan (Avapro), losartan (Cozaar),

Birth control and Hormone replacement therapy

Anti-psychotic drugs: Haloperidol, phenothiazines, phenytoin (Dilantin) (for seizures), halothane (anaesthetics)

Drugs metabolised by liver enzymes, (Cytochrome P450…):

Allergy drugs

Cholesterol drugs: Atorvastatin (Lipitor), fluvastatin (Lescol), lovastatin (Mevacor), rosuvastatin (Crestor)

Anxiolytic drugs: Diazepam (Valium), Lorazapam (Ativan), oxazepam (Serax),

Anti-depressants: Amitriptyline (Elavil),

Parkinsons: Entacapone (Comtan)

Anti-epileptic:lamotrigine( Lamictal),

Asthma drugs: Zileuton (Zyflo),

Arthritis and anti-inflammatory drugs: Celecoxib (Celebrex), diclofenac (Voltaren), ibuprofen (Advil, Motrin), piroxicam (Feldene),

Anti- platelet, anti-coagulant drugs: Plavix, Warfarin

Some cancer drugs: Irinotecan (Camptosar), Tamoxifen (Nolvadex)

Pregnancy and lactation: Not to be taken during pregnancy and breast feeding

Dosage and directions for use: Take one to two capsules twice daily or as prescribed.

Please discuss your condition with a practitioner before using Milk Thistle. For the treatment of inflammatory bowel disease or psoriasis, please ensure that the condition has been

diagnosed by a practitioner. Should inflammatory bowel symptoms not improve within 4 weeks, and psoriasis within 3 months, please consult your practitioner.

Side-effects and special precautions: Milk Thistle is generally regarded as safe; side effects are mild and may be stomach upset and diarrhoea. Reduce dosage and discuss with practitioner.

Known symptoms of over dosage and particulars of its treatment: None known.

Identification: Clear size 0 all vegetable capsule containing pale green herbal powder.

Presentation: 60 Capsules packed into 125ml amber glass bottle with light green screw cap and safety seal insert, 500 Capsules packed into a 109x117mm securitainer with tamper evident seal.

Storage instructions: Store below 25ºC. KEEP OUT OF REACH OF CHILDREN.

Applicant: Flora Force Health Products (Pty) Ltd., PO Box 426, Rondebosch, 7701, Cape Town

Registration number: To be allocated.

Date of Publication: 09/07/2015